You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML in lymphoid blast crisis patients

Showing 1 - 25 of 1,785
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Chicago, Illinois
  • +5 more
Dec 27, 2021

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Orca-Q
  • Gainesville, Florida
    University of Florida
Aug 26, 2022

Chronic Myeloid Leukemia in Myeloid Blast Crisis Trial in Worldwide

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • Brno, Czechia
    • +8 more
    Jan 27, 2021

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

    Completed
    • Myelodysplastic Syndrome RAEB-I or RAEB-II
    • +2 more
    • GM-CSF secreting leukemia vaccine
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 28, 2022

    Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

    Completed
    Has Results
    • Philadelphia Chromosome Positive CML
    • imatinib mesylate
    • Chicago, Illinois
    • +9 more
    Jun 3, 2021

    CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

    Completed
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
      • Limerick, Dooradoyle, Ireland
      • +32 more
      Aug 13, 2021

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +4 more
      • Eltrombopag Olamine
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 4, 2022

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • +3 more
      • Duarte, California
      • +100 more
      Jun 8, 2021

      Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

      Recruiting
      • Acute Myeloid Leukemia
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 31, 2022

      Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

      Completed
      Has Results
      • Philadelphia Positive Chronic Myeloid Leukemia
      • +2 more
      • STI571 400 mg
      • STI571 600 mg
      • Boston, Massachusetts
      • +11 more
      Jul 1, 2021

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +7 more
      • Blinatumomab
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

      Completed
      Has Results
      • Acute Myeloid Leukemia
      • +2 more
      • Clofarabine 40mg/m^2
      • +5 more
      • Houston, Texas
        UT MD Anderson Cancer Center
      Dec 3, 2020

      Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

      Terminated
      • Accelerated Phase Chronic Myelogenous Leukemia (CML)
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 17, 2020

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

      Completed
      • Chronic Phase Chronic Myeloid Leukemia
      • +4 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital / University Health Network
      Oct 29, 2020

      Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      Has Results
      • Leukemia
      • Birmingham, Alabama
      • +173 more
      Dec 1, 2022

      Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

      Completed
      Has Results
      • Chronic Myeloid Leukemia
      • Omacetaxine mepesuccinate
      • Los Angeles, California
      • +31 more
      Nov 11, 2021

      According to Molecular Identification at Diagnosis

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Next Generation Sequencing (DNA and RNA)
      • (no location specified)
      Oct 28, 2022

      Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

      Recruiting
      • Chronic Myelogenous Leukemia - Chronic Phase
      • Birmingham, Alabama
      • +25 more
      Jan 10, 2023

      Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

      Completed
      • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
      • Angers, France
      • +9 more
      Aug 17, 2022

      Describe Real World Use of Bosutinib inSingle Centre in Scotland

      Completed
      • Myeloid Leukemia
      • Glasgow, United Kingdom
        eatson West of Scotland Cancer Centre
      May 3, 2022